Efficacy of infliximab after loss of response of/intolerance to adalimumab in pediatric Crohn's disease: A retrospective multicenter cohort study of the "GETAID pédiatrique".
Lecoutour A, Dupont C, Caldari D, Dumant C, Vanrenterghem A, Ruiz M, Duclaux-Loras R, Berthet S, Dimitrov G, Lacroix D, Duvant P, Roman C, Wagner AC, Bourmaud A, Viala J, Ruemmele FM, Pigneur B; GETAID pédiatrique group.
Lecoutour A, et al. Among authors: bourmaud a.
J Pediatr Gastroenterol Nutr. 2024 May;78(5):1116-1125. doi: 10.1002/jpn3.12044. Epub 2024 Jan 7.
J Pediatr Gastroenterol Nutr. 2024.
PMID: 38314896